A Greek-designed ERAS Protocol in Elective Craniotomy (ERAS)

July 26, 2023 updated by: Elena Arnaoutoglou, University of Thessaly

A Greek-designed Enhanced Recovery After Surgery (ERAS) Protocol in Elective Cranial Neurosurgical Procedures: An Observational Study

The implementation of ERAS protocol in elective cranial neurosurgical cases in a tertiary hospital.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

In this study, the investigators have integrated the most current data from literature aiming to investigate the effectiveness of a contemporary ERAS protocol for elective cranial neurosurgical cases in a tertiary hospital. The hypothesis is that the implementation of such protocol will shorten the postoperative length of stay, minimize the complication rates, and improve the overall clinical status of patients undergoing elective craniotomy compared to the standard perioperative care

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Larissa, Greece, 41110
        • Recruiting
        • University of Thessaly
        • Sub-Investigator:
          • Alexandros Brotis, MD, PhD
        • Contact:
        • Principal Investigator:
          • Eleni Arnaoutoglou, MD, PhD
        • Contact:
        • Principal Investigator:
          • Konstantinos Fountas, MD, PhD
        • Sub-Investigator:
          • Metaxia Bareka, MD, PhD
        • Sub-Investigator:
          • Mary Solou, MD, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Adult patients undergoing elective craniotomy

Description

Inclusion Criteria:

  • Medically suitable for elective craniotomy
  • ASA-PS I-III

Exclusion Criteria:

  • traumatic lesions
  • pathology requiring emergent surgery
  • preoperative loss of consciousness
  • severe co-morbidities that may affect postoperative recovery (e.g. paralysis, autoimmune diseases, myocardial or severe infarction, heart, liver or lung malfunction, severe mental illness etc.)
  • recurrent tumor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ERAS
Implementation of ERAS protocol in elective craniotomy patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital Length of Stay
Time Frame: up to 7 days
The days the patient stays in hospital
up to 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score
Time Frame: Postoperative Day 1 to discharge, an average of 7 days
Pain intensity as measured by Visual Analogue Scale (VAS)
Postoperative Day 1 to discharge, an average of 7 days
Mental status
Time Frame: 1 day at discharge
Mental status as measured by Glasgow Coma Scale (GCS) Minimum value : 3 Maximum value : 15 Higher scores mean a better outcome
1 day at discharge
Patient's satisfaction
Time Frame: 1 day at discharge and 1 month postoperatively
Patient's satisfaction as measured by a Likert Scale
1 day at discharge and 1 month postoperatively
Anxiety and Depression
Time Frame: Preoperatively, second postoperative day and one month postoperatively
Anxiety and Depression level as measured by Hospital Anxiety and Depression Scale (HADS)
Preoperatively, second postoperative day and one month postoperatively
Personality Index
Time Frame: Preoperatively, second postoperative day and one month postoperatively
Personality Index as measured by TIPI
Preoperatively, second postoperative day and one month postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Eleni Arnaoutolglou, MD, PhD, University of Thessaly
  • Study Chair: Konstantinos Fountas, MD, PhD, University of Thessaly

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2023

Primary Completion (Estimated)

May 31, 2024

Study Completion (Estimated)

July 30, 2024

Study Registration Dates

First Submitted

July 12, 2023

First Submitted That Met QC Criteria

July 26, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 26, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ERAS Craniotomy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe